Skip to main content
. 2024 Feb 7;15:1325186. doi: 10.3389/fphar.2024.1325186

TABLE 1.

Number of patients providing blood samples for both pharmacokinetic and pharmacodynamic analyses at the start and end of infusion (within the last 10 minutes) by treatment and visit.

Treatment week Placebo (n = 15) 300 mg (n = 20) 600 mg (n = 20) Total (n = 55)
Week 1 8 (53.3) 11 (55.0) 9 (45.0) 28 (50.9)
Week 10 9 (60.0) 12 (60.0) 9 (45.0) 30 (54.5)
Week 22 9 (60.0) 11 (55.0) 15 (75.0) 35 (63.6)
Week 52 8 (53.3) 10 (50.0) 6 (30.0) 23 (41.8)

Data are shown as n (%).